Thailand's Food and Drug Administration (FDA) has introduced a rule accepting approvals from reference countries for medical device change applications. Review times have been shortened to 15 to 35 working days, and external expert review is no longer required.
The rule also provides a five-working-day response window for smaller applications and a 10-working-day window for other applications.

By accepting reference-country approvals and removing external expert review, the rule simplifies the process for registering device changes in Thailand. The shorter review period may help applicants plan regulatory work with greater certainty and reduce compliance costs.
The practical benefit for an individual application will depend on how the rule applies to the proposed change, including which response window is assigned. Further regulatory information will be relevant to understanding the scope of eligible changes and how the process operates in practice.
Have questions about the global trade trends discussed here, or planning your expansion and supply chain strategy? Leave a message below and let the trade experts at MTHH guide you.
We respect your privacy. Your information is strictly confidential.
Related News